Necrotizing enterocolitis: current understanding of the prevention and management
link.springer.com shows its articles on its own site.
Read the article on link.springer.com ↗Article · Jan 2024 · 1 min read
In brief
In brief
This review synthesizes current evidence on necrotizing enterocolitis (NEC) prevention and management in preterm neonates. The authors present risk-stratified prevention strategies, Bell's staging-based treatment protocols, and emerging biomarkers for early detection and intervention.
Written by the GCMD Library team from the article.
Abstract
Necrotizing enterocolitis (NEC) is one of the diseases in neonates, with a high morbidity and mortality rate, especially in preterm infants. This review aimed to briefly introduce the latest epidemiology, susceptibility factors, and clinical diagnosis and presentation of NEC. We also organized new prevention strategies by risk factors according to different pathogeneses and then discussed new treatment methods based on Bell's staging and complications, and the classification of mild to high severity based on clinical and imaging manifestations. Such a generalization will help clinicians and researchers to gain a deeper understanding of the disease and to conduct more targeted classification, grading prevention, and exploration. We focused on prevention and treatment of the early and suspected stages of NEC, including the discovery of novel biomarkers and drugs to control disease progression. At the same time, we discussed its clinical application, future development, and shortcomings.